StockData
Q32 Bio Inc. logo

Q32 Bio Inc. (QTTB) stock

QTTBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 8/30
$8.53−0.10 (-1.16%)

Close on Nov 18, 2026Market cap $253.93MP/E –Yield –

Q32 Bio price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Q32 Bio's price to sales ratio was 304.8× on Oct 31, 2024, against 1.6× a year earlier. Over the last 5 years it ranged from 0.3× to 304.8×, with a median of 3.0×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2024Oct 31, 2024304.8×+304.3
2023Dec 29, 20230.4×−2.0
2022Dec 30, 20222.4×+1.8
2021Dec 31, 20210.7×−23.6
2020Dec 31, 202024.2×−18.7
2019Dec 31, 201942.9×–

More Q32 Bio figures

See a number that looks wrong?